Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Ximino (minocycline hydrochloride) Extended-Release Capsules, 45 mg, 67.5 mg, 90 mg, 112.5 mg, and 135 mg
Company: Ranbaxy Laboratories Limited
Application No.: 201922
Approval Date: 07/11/2012

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

 

Date created: August 13, 2013

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-